UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Annals of the rheumatic diseases, 2012-12, Vol.71 (12), p.1950-1954

2012

Volltextzugriff (PDF)

Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution

Postgraduate Medical Journal, 2007-04, Vol.83 (978), p.251-260

2007

Volltextzugriff (PDF)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician

Biologics, 2021-01, Vol.15, p.343-352

2021

Volltextzugriff (PDF)

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies

Arthritis research & therapy, 2016-12, Vol.18 (1), p.302-302, Article 302

2016

Volltextzugriff (PDF)

Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom

Clinical rheumatology, 2015-12, Vol.34 (12), p.2141-2145

2015

Volltextzugriff (PDF)

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Rheumatology (Oxford, England), 2010-02, Vol.49 (2), p.295-307

2010

Volltextzugriff (PDF)

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Rheumatology (Oxford, England), 2011-03, Vol.50 (3), p.518-531

2011

Volltextzugriff (PDF)

Contemporary treatment principles for early rheumatoid arthritis: a consensus statement

Rheumatology (Oxford, England), 2009-07, Vol.48 (7), p.765-772

2009

Volltextzugriff (PDF)

Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review

Clinical rheumatology, 2011-11, Vol.30 (11), p.1471-1474

2011

Volltextzugriff (PDF)

Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review

Rheumatology (Oxford, England), 2011-12, Vol.50 (12), p.2297-2305

2011

Volltextzugriff (PDF)

Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis

Journal of the American Heart Association, 2016-02, Vol.5 (2), p.n/a

2016

Volltextzugriff (PDF)

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial

Rheumatology (Oxford, England), 2018-01, Vol.57 (1), p.84-91

2018

Volltextzugriff (PDF)

Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort

Clinical rheumatology, 2014-05, Vol.33 (5), p.609-614

2014

Volltextzugriff (PDF)

Interleukin-6 and cytochrome-P450, reason for concern?

Rheumatology international, 2012-09, Vol.32 (9), p.2601-2604

2012

Volltextzugriff (PDF)

The prevalence and impact of polypharmacy in rheumatology

Rheumatology (Oxford, England), 2023-10, Vol.62 (SI3), p.SI237-SI241

2023

Volltextzugriff (PDF)

Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice

Clinical rheumatology, 2019-09, Vol.38 (9), p.2411-2421

2019

Volltextzugriff (PDF)

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

Clinical rheumatology, 2015-03, Vol.34 (3), p.563-571

2015

Volltextzugriff (PDF)

What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence

Clinical rheumatology, 2013-06, Vol.32 (6), p.729-734

2013

Volltextzugriff (PDF)

Biologic agents for rheumatoid arthritis-negotiating the NICE technology appraisals

Rheumatology (Oxford, England), 2012-01, Vol.51 (1), p.24-31

2012

Volltextzugriff (PDF)

Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis

Circulation (New York, N.Y.), 2012-11, Vol.126 (21), p.2473-2480

2012

Volltextzugriff (PDF)

Update on biosimilars in rheumatology

Inflammopharmacology, 2017-04, Vol.25 (2), p.177-184

2017

Volltextzugriff (PDF)

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

Rheumatic & musculoskeletal diseases open, 2022-03, Vol.8 (1), p.e002049

2022

Volltextzugriff (PDF)

Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?

Journal of clinical rheumatology, 2017-03, Vol.23 (2), p.125-126

2017

Volltextzugriff (PDF)

Non-infectious pulmonary toxicity of rituximab: a systematic review

Rheumatology (Oxford, England), 2012-04, Vol.51 (4), p.653-662

2012

Volltextzugriff (PDF)

Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials

Rheumatology (Oxford, England), 2011-03, Vol.50 (3), p.552-562

2011

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(71)
Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Rheumatology
(60)
Arthritis, Rheumatoid - Drug Therapy
(40)
Rheumatoid Arthritis
(37)
Antirheumatic Agents - Therapeutic Use
(31)
Male
(22)
Adult
(21)
Female
(21)
Middle Aged
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Treatment Outcome
(20)
Aged
(19)
Antirheumatic Agents - Adverse Effects
(18)
Diseases Of The Osteoarticular System
(18)
Inflammatory Joint Diseases
(16)
Medicine
(16)
Medicine & Public Health
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies

Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Contemporary treatment principles for early rheumatoid arthritis: a consensus statement

Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review

Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review

Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial

Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort

Interleukin-6 and cytochrome-P450, reason for concern?

The prevalence and impact of polypharmacy in rheumatology

Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice

What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence

Biologic agents for rheumatoid arthritis-negotiating the NICE technology appraisals

Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis

Update on biosimilars in rheumatology

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?

Non-infectious pulmonary toxicity of rituximab: a systematic review

Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials

Suchergebnisse filtern